How Lantern Pharma and Code Ocean Partnered on Oncology Drug Development

When Peter Carr, principal software architect of Lantern Pharma, stepped into his full-time role in September 2020, the company was on the cusp of a transformation. In a prior position, Carr served as a senior software engineer at the Broad Institute, which used GenePattern, an open-source tool for reproducible research in genomics. “When I came to this company, I thought, ‘Oh, we need something like that,'” Carr recalled. “But GenePattern is not a commercial product, so it lacks a bit of polish.” This led Carr to explore other options, ultimately landing on as the best fit for Lantern Pharma.

The biggest win at Lantern is the pipeline we developed, and the value of Code Ocean was that it allowed the whole team to work together,” Carr said. Promoting collaboration was not a problem that could be solved by a single individual with a laptop. “Instead, we were able to have a shared environment for collaboration, which was a huge win that Code Ocean enabled us to achieve,” Carr said.